ChromaDex (NASDAQ: CDXC) reported Q3 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $8.37 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.